nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—ESR1—Alzheimer's disease	0.407	1	CbGaD
Medroxyprogesterone Acetate—CYP2C9—Donepezil—Alzheimer's disease	0.0756	0.373	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Rivastigmine—Alzheimer's disease	0.055	0.271	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Donepezil—Alzheimer's disease	0.0439	0.217	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Galantamine—Alzheimer's disease	0.0283	0.14	CbGbCtD
Medroxyprogesterone Acetate—HSD3B2—nervous system—Alzheimer's disease	0.00221	0.0798	CbGeAlD
Medroxyprogesterone Acetate—PGR—blood vessel—Alzheimer's disease	0.00221	0.0796	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—central nervous system—Alzheimer's disease	0.00213	0.0768	CbGeAlD
Medroxyprogesterone Acetate—ESR1—blood vessel—Alzheimer's disease	0.00173	0.0622	CbGeAlD
Medroxyprogesterone Acetate—HSD3B2—brain—Alzheimer's disease	0.00169	0.061	CbGeAlD
Medroxyprogesterone Acetate—ESR1—embryo—Alzheimer's disease	0.00103	0.0371	CbGeAlD
Medroxyprogesterone Acetate—AR—forebrain—Alzheimer's disease	0.000927	0.0335	CbGeAlD
Medroxyprogesterone Acetate—ESR1—forebrain—Alzheimer's disease	0.00091	0.0328	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—cerebellum—Alzheimer's disease	0.000878	0.0317	CbGeAlD
Medroxyprogesterone Acetate—AR—telencephalon—Alzheimer's disease	0.000853	0.0308	CbGeAlD
Medroxyprogesterone Acetate—ESR1—telencephalon—Alzheimer's disease	0.000837	0.0302	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—embryo—Alzheimer's disease	0.00076	0.0274	CbGeAlD
Medroxyprogesterone Acetate—AKR1C3—brain—Alzheimer's disease	0.000713	0.0257	CbGeAlD
Medroxyprogesterone Acetate—SHBG—central nervous system—Alzheimer's disease	0.000675	0.0244	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—forebrain—Alzheimer's disease	0.000672	0.0242	CbGeAlD
Medroxyprogesterone Acetate—Ethynodiol—ESR1—Alzheimer's disease	0.00067	0.345	CrCbGaD
Medroxyprogesterone Acetate—SHBG—cerebellum—Alzheimer's disease	0.00066	0.0238	CbGeAlD
Medroxyprogesterone Acetate—PGR—nervous system—Alzheimer's disease	0.000632	0.0228	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—telencephalon—Alzheimer's disease	0.000618	0.0223	CbGeAlD
Medroxyprogesterone Acetate—PGR—central nervous system—Alzheimer's disease	0.000608	0.0219	CbGeAlD
Medroxyprogesterone Acetate—PGR—cerebellum—Alzheimer's disease	0.000595	0.0214	CbGeAlD
Medroxyprogesterone Acetate—SHBG—brain—Alzheimer's disease	0.000536	0.0193	CbGeAlD
Medroxyprogesterone Acetate—AR—nervous system—Alzheimer's disease	0.000503	0.0182	CbGeAlD
Medroxyprogesterone Acetate—ESR1—nervous system—Alzheimer's disease	0.000494	0.0178	CbGeAlD
Medroxyprogesterone Acetate—AR—central nervous system—Alzheimer's disease	0.000485	0.0175	CbGeAlD
Medroxyprogesterone Acetate—PGR—brain—Alzheimer's disease	0.000483	0.0174	CbGeAlD
Medroxyprogesterone Acetate—ESR1—central nervous system—Alzheimer's disease	0.000476	0.0172	CbGeAlD
Medroxyprogesterone Acetate—ESR1—cerebellum—Alzheimer's disease	0.000465	0.0168	CbGeAlD
Medroxyprogesterone Acetate—Drospirenone—BCHE—Alzheimer's disease	0.000463	0.239	CrCbGaD
Medroxyprogesterone Acetate—AR—brain—Alzheimer's disease	0.000385	0.0139	CbGeAlD
Medroxyprogesterone Acetate—ESR1—brain—Alzheimer's disease	0.000378	0.0136	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—nervous system—Alzheimer's disease	0.000365	0.0132	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—central nervous system—Alzheimer's disease	0.000351	0.0127	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—cerebellum—Alzheimer's disease	0.000343	0.0124	CbGeAlD
Medroxyprogesterone Acetate—Fluoxymesterone—ESR1—Alzheimer's disease	0.000332	0.171	CrCbGaD
Medroxyprogesterone Acetate—CYP2C8—brain—Alzheimer's disease	0.000311	0.0112	CbGeAlD
Medroxyprogesterone Acetate—NR3C1—brain—Alzheimer's disease	0.000279	0.0101	CbGeAlD
Medroxyprogesterone Acetate—CYP3A4—nervous system—Alzheimer's disease	0.000276	0.00995	CbGeAlD
Medroxyprogesterone Acetate—Sinusitis—Rivastigmine—Alzheimer's disease	0.000266	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—central nervous system—Alzheimer's disease	0.000266	0.00958	CbGeAlD
Medroxyprogesterone Acetate—Confusional state—Galantamine—Alzheimer's disease	0.000265	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Memantine—Alzheimer's disease	0.000265	0.00104	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Memantine—Alzheimer's disease	0.000262	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Memantine—Alzheimer's disease	0.00026	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Memantine—Alzheimer's disease	0.00026	0.00102	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Rivastigmine—Alzheimer's disease	0.000259	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Galantamine—Alzheimer's disease	0.000259	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Memantine—Alzheimer's disease	0.000258	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Galantamine—Alzheimer's disease	0.000258	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000257	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Donepezil—Alzheimer's disease	0.000257	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Memantine—Alzheimer's disease	0.000257	0.00101	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Galantamine—Alzheimer's disease	0.000256	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Memantine—Alzheimer's disease	0.000256	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Rivastigmine—Alzheimer's disease	0.000256	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Memantine—Alzheimer's disease	0.000256	0.001	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Galantamine—Alzheimer's disease	0.000255	0.000998	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Memantine—Alzheimer's disease	0.000255	0.000998	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Rivastigmine—Alzheimer's disease	0.000255	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Rivastigmine—Alzheimer's disease	0.000255	0.000996	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000254	0.000994	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Donepezil—Alzheimer's disease	0.000253	0.000991	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Rivastigmine—Alzheimer's disease	0.000253	0.000988	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.000251	0.000983	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Donepezil—Alzheimer's disease	0.000251	0.000982	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Rivastigmine—Alzheimer's disease	0.000251	0.000981	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Memantine—Alzheimer's disease	0.000251	0.000981	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Galantamine—Alzheimer's disease	0.00025	0.00098	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00025	0.000979	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00025	0.000976	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Donepezil—Alzheimer's disease	0.00025	0.000976	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Donepezil—Alzheimer's disease	0.00025	0.000976	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Memantine—Alzheimer's disease	0.000246	0.000962	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Donepezil—Alzheimer's disease	0.000246	0.000962	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Galantamine—Alzheimer's disease	0.000246	0.00096	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Rivastigmine—Alzheimer's disease	0.000245	0.00096	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Donepezil—Alzheimer's disease	0.000245	0.000958	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Donepezil—Alzheimer's disease	0.000244	0.000956	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Memantine—Alzheimer's disease	0.000243	0.000951	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Memantine—Alzheimer's disease	0.000243	0.000949	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Donepezil—Alzheimer's disease	0.000242	0.000948	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Memantine—Alzheimer's disease	0.000242	0.000945	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Donepezil—Alzheimer's disease	0.000241	0.000944	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000241	0.000942	CcSEcCtD
Medroxyprogesterone Acetate—Muscle spasms—Donepezil—Alzheimer's disease	0.00024	0.000938	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.000239	0.000936	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Rivastigmine—Alzheimer's disease	0.000238	0.000931	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Galantamine—Alzheimer's disease	0.000238	0.00093	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Rivastigmine—Alzheimer's disease	0.000237	0.000928	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.000236	0.000924	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Memantine—Alzheimer's disease	0.000236	0.000924	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Galantamine—Alzheimer's disease	0.000236	0.000923	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Memantine—Alzheimer's disease	0.000235	0.000919	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Memantine—Alzheimer's disease	0.000235	0.000917	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Donepezil—Alzheimer's disease	0.000234	0.000914	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Galantamine—Alzheimer's disease	0.000234	0.000914	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Memantine—Alzheimer's disease	0.000234	0.000913	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Donepezil—Alzheimer's disease	0.000231	0.000906	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Galantamine—Alzheimer's disease	0.000231	0.000905	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Rivastigmine—Alzheimer's disease	0.000231	0.000904	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Donepezil—Alzheimer's disease	0.000231	0.000902	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Memantine—Alzheimer's disease	0.00023	0.0009	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000229	0.000897	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Donepezil—Alzheimer's disease	0.000229	0.000897	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Rivastigmine—Alzheimer's disease	0.000228	0.000894	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Galantamine—Alzheimer's disease	0.000228	0.000893	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Memantine—Alzheimer's disease	0.000228	0.000892	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000227	0.000887	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Memantine—Alzheimer's disease	0.000227	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Galantamine—Alzheimer's disease	0.000227	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Donepezil—Alzheimer's disease	0.000225	0.00088	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Rivastigmine—Alzheimer's disease	0.000225	0.00088	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Galantamine—Alzheimer's disease	0.000225	0.000879	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Donepezil—Alzheimer's disease	0.000224	0.000877	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Donepezil—Alzheimer's disease	0.000224	0.000875	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Memantine—Alzheimer's disease	0.000223	0.000873	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Rivastigmine—Alzheimer's disease	0.000223	0.000872	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Memantine—Alzheimer's disease	0.000222	0.00087	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Memantine—Alzheimer's disease	0.000222	0.000868	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Rivastigmine—Alzheimer's disease	0.000222	0.000867	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Rivastigmine—Alzheimer's disease	0.000222	0.000867	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Memantine—Alzheimer's disease	0.00022	0.000861	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Donepezil—Alzheimer's disease	0.000219	0.000858	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Memantine—Alzheimer's disease	0.000219	0.000857	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Rivastigmine—Alzheimer's disease	0.000218	0.000854	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Rivastigmine—Alzheimer's disease	0.000217	0.000851	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000217	0.000849	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Galantamine—Alzheimer's disease	0.000217	0.000847	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Donepezil—Alzheimer's disease	0.000216	0.000846	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Rivastigmine—Alzheimer's disease	0.000215	0.000842	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000215	0.00084	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Rivastigmine—Alzheimer's disease	0.000214	0.000839	CcSEcCtD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—Alzheimer's disease	0.000214	0.11	CrCbGaD
Medroxyprogesterone Acetate—Muscle spasms—Rivastigmine—Alzheimer's disease	0.000213	0.000833	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Donepezil—Alzheimer's disease	0.000212	0.000831	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Donepezil—Alzheimer's disease	0.000212	0.000831	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Donepezil—Alzheimer's disease	0.000212	0.000831	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Memantine—Alzheimer's disease	0.000212	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Donepezil—Alzheimer's disease	0.000212	0.000828	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Memantine—Alzheimer's disease	0.00021	0.000822	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Donepezil—Alzheimer's disease	0.00021	0.000821	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Memantine—Alzheimer's disease	0.000209	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Memantine—Alzheimer's disease	0.000208	0.000814	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Donepezil—Alzheimer's disease	0.000208	0.000813	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Galantamine—Alzheimer's disease	0.000208	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Galantamine—Alzheimer's disease	0.000208	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Tremor—Rivastigmine—Alzheimer's disease	0.000208	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Rivastigmine—Alzheimer's disease	0.000206	0.000804	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Donepezil—Alzheimer's disease	0.000205	0.000803	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Rivastigmine—Alzheimer's disease	0.000205	0.000801	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Memantine—Alzheimer's disease	0.000204	0.000799	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Rivastigmine—Alzheimer's disease	0.000204	0.000797	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Donepezil—Alzheimer's disease	0.000204	0.000797	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Memantine—Alzheimer's disease	0.000204	0.000796	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Memantine—Alzheimer's disease	0.000203	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Donepezil—Alzheimer's disease	0.000202	0.000791	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Donepezil—Alzheimer's disease	0.0002	0.000784	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Memantine—Alzheimer's disease	0.0002	0.000783	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Rivastigmine—Alzheimer's disease	0.0002	0.000782	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Donepezil—Alzheimer's disease	0.0002	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000199	0.00078	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Rivastigmine—Alzheimer's disease	0.000199	0.000779	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Memantine—Alzheimer's disease	0.000199	0.000779	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Rivastigmine—Alzheimer's disease	0.000199	0.000777	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000197	0.00077	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Memantine—Alzheimer's disease	0.000196	0.000768	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Rivastigmine—Alzheimer's disease	0.000196	0.000766	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000195	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Donepezil—Alzheimer's disease	0.000194	0.000759	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Galantamine—Alzheimer's disease	0.000194	0.000757	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Memantine—Alzheimer's disease	0.000193	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Memantine—Alzheimer's disease	0.000193	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Memantine—Alzheimer's disease	0.000193	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Memantine—Alzheimer's disease	0.000192	0.000752	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Rivastigmine—Alzheimer's disease	0.000192	0.000751	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Memantine—Alzheimer's disease	0.000191	0.000745	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Donepezil—Alzheimer's disease	0.00019	0.000744	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Rivastigmine—Alzheimer's disease	0.000189	0.000738	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Rivastigmine—Alzheimer's disease	0.000189	0.000738	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Rivastigmine—Alzheimer's disease	0.000189	0.000738	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Memantine—Alzheimer's disease	0.000189	0.000738	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Galantamine—Alzheimer's disease	0.000189	0.000737	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Rivastigmine—Alzheimer's disease	0.000188	0.000735	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000187	0.000733	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Memantine—Alzheimer's disease	0.000186	0.000729	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Rivastigmine—Alzheimer's disease	0.000186	0.000729	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.000186	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Memantine—Alzheimer's disease	0.000185	0.000723	CcSEcCtD
Medroxyprogesterone Acetate—Dry mouth—Rivastigmine—Alzheimer's disease	0.000185	0.000722	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Donepezil—Alzheimer's disease	0.000184	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Memantine—Alzheimer's disease	0.000184	0.000718	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Donepezil—Alzheimer's disease	0.000183	0.000715	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Rivastigmine—Alzheimer's disease	0.000182	0.000713	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Memantine—Alzheimer's disease	0.000182	0.000712	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Donepezil—Alzheimer's disease	0.000182	0.00071	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Memantine—Alzheimer's disease	0.000181	0.000709	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Donepezil—Alzheimer's disease	0.000181	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Memantine—Alzheimer's disease	0.000181	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Rivastigmine—Alzheimer's disease	0.000181	0.000708	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Memantine—Alzheimer's disease	0.00018	0.000706	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Galantamine—Alzheimer's disease	0.00018	0.000703	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Rivastigmine—Alzheimer's disease	0.00018	0.000703	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Memantine—Alzheimer's disease	0.00018	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Donepezil—Alzheimer's disease	0.000179	0.000701	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Memantine—Alzheimer's disease	0.000179	0.000699	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Rivastigmine—Alzheimer's disease	0.000178	0.000696	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000177	0.000694	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000177	0.000693	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Donepezil—Alzheimer's disease	0.000177	0.000692	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Rivastigmine—Alzheimer's disease	0.000177	0.000691	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Memantine—Alzheimer's disease	0.000176	0.000689	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000176	0.000688	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Rivastigmine—Alzheimer's disease	0.000176	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Donepezil—Alzheimer's disease	0.000176	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000175	0.000684	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Donepezil—Alzheimer's disease	0.000174	0.000681	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Galantamine—Alzheimer's disease	0.000174	0.00068	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Memantine—Alzheimer's disease	0.000173	0.000676	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Rivastigmine—Alzheimer's disease	0.000172	0.000674	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Rivastigmine—Alzheimer's disease	0.000169	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.000168	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Donepezil—Alzheimer's disease	0.000168	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Memantine—Alzheimer's disease	0.000167	0.000654	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Galantamine—Alzheimer's disease	0.000167	0.000653	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000167	0.000651	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Memantine—Alzheimer's disease	0.000166	0.000649	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Galantamine—Alzheimer's disease	0.000166	0.000648	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Galantamine—Alzheimer's disease	0.000166	0.000647	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Memantine—Alzheimer's disease	0.000165	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.000165	0.000645	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—ESR1—Alzheimer's disease	0.000165	0.0848	CrCbGaD
Medroxyprogesterone Acetate—Headache—Galantamine—Alzheimer's disease	0.000165	0.000644	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Memantine—Alzheimer's disease	0.000164	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Rivastigmine—Alzheimer's disease	0.000164	0.00064	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Memantine—Alzheimer's disease	0.000163	0.000637	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000162	0.000635	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Donepezil—Alzheimer's disease	0.000162	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Rivastigmine—Alzheimer's disease	0.000161	0.000631	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Donepezil—Alzheimer's disease	0.000161	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Donepezil—Alzheimer's disease	0.000161	0.00063	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Rivastigmine—Alzheimer's disease	0.000161	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Memantine—Alzheimer's disease	0.000161	0.000629	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00016	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Memantine—Alzheimer's disease	0.000159	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000159	0.000623	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Memantine—Alzheimer's disease	0.000158	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000157	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000156	0.000611	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Galantamine—Alzheimer's disease	0.000156	0.00061	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Rivastigmine—Alzheimer's disease	0.000156	0.00061	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Rivastigmine—Alzheimer's disease	0.000155	0.000605	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Memantine—Alzheimer's disease	0.000152	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000151	0.000591	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Donepezil—Alzheimer's disease	0.00015	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000149	0.000583	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000148	0.000579	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Memantine—Alzheimer's disease	0.000147	0.000575	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Memantine—Alzheimer's disease	0.000146	0.000572	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Memantine—Alzheimer's disease	0.000146	0.000572	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Donepezil—Alzheimer's disease	0.000146	0.000571	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Donepezil—Alzheimer's disease	0.000144	0.000564	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Rivastigmine—Alzheimer's disease	0.000144	0.000562	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000143	0.000559	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000143	0.000559	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Donepezil—Alzheimer's disease	0.000139	0.000545	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Memantine—Alzheimer's disease	0.000136	0.000533	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Donepezil—Alzheimer's disease	0.000135	0.000527	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000133	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Memantine—Alzheimer's disease	0.000133	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Memantine—Alzheimer's disease	0.000131	0.000512	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Rivastigmine—Alzheimer's disease	0.00013	0.000508	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Donepezil—Alzheimer's disease	0.000129	0.000506	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Donepezil—Alzheimer's disease	0.000128	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Donepezil—Alzheimer's disease	0.000128	0.000502	CcSEcCtD
Medroxyprogesterone Acetate—Pruritus—Rivastigmine—Alzheimer's disease	0.000128	0.000501	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Donepezil—Alzheimer's disease	0.000128	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Memantine—Alzheimer's disease	0.000127	0.000495	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000124	0.000484	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Memantine—Alzheimer's disease	0.000122	0.000478	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Donepezil—Alzheimer's disease	0.000121	0.000473	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Rivastigmine—Alzheimer's disease	0.00012	0.000468	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Memantine—Alzheimer's disease	0.000118	0.00046	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Memantine—Alzheimer's disease	0.000117	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Memantine—Alzheimer's disease	0.000116	0.000456	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Memantine—Alzheimer's disease	0.000116	0.000453	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Rivastigmine—Alzheimer's disease	0.000115	0.00045	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Rivastigmine—Alzheimer's disease	0.000114	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Rivastigmine—Alzheimer's disease	0.000114	0.000446	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Rivastigmine—Alzheimer's disease	0.000113	0.000443	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Memantine—Alzheimer's disease	0.00011	0.00043	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Rivastigmine—Alzheimer's disease	0.000107	0.00042	CcSEcCtD
Medroxyprogesterone Acetate—Progesterone—CYP2D6—Alzheimer's disease	9.8e-05	0.0505	CrCbGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1R—Alzheimer's disease	2.24e-05	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APH1A—Alzheimer's disease	2.23e-05	0.000214	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—AKT1—Alzheimer's disease	2.23e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PLCB1—Alzheimer's disease	2.23e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—GSK3B—Alzheimer's disease	2.22e-05	0.000213	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—AKT1—Alzheimer's disease	2.21e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ATP5A1—Alzheimer's disease	2.21e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—CREB1—Alzheimer's disease	2.21e-05	0.000211	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—INS—Alzheimer's disease	2.19e-05	0.00021	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	2.18e-05	0.000209	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NCSTN—Alzheimer's disease	2.18e-05	0.000208	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CALM1—Alzheimer's disease	2.16e-05	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—APOE—Alzheimer's disease	2.15e-05	0.000206	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LPL—Alzheimer's disease	2.15e-05	0.000205	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CAV1—Alzheimer's disease	2.13e-05	0.000204	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MEF2C—Alzheimer's disease	2.13e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LRP1—Alzheimer's disease	2.12e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLD3—Alzheimer's disease	2.11e-05	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—Alzheimer's disease	2.11e-05	0.000202	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—PRKCG—Alzheimer's disease	2.09e-05	0.0002	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Alzheimer's disease	2.09e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ESR1—Alzheimer's disease	2.08e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGFR—Alzheimer's disease	2.08e-05	0.000199	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GFAP—Alzheimer's disease	2.07e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GAL—Alzheimer's disease	2.07e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	2.07e-05	0.000198	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NGF—Alzheimer's disease	2.03e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ADAM10—Alzheimer's disease	2.03e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HSD17B10—Alzheimer's disease	2.02e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—NOTCH1—Alzheimer's disease	2.01e-05	0.000193	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCR5—Alzheimer's disease	1.98e-05	0.000189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—Alzheimer's disease	1.98e-05	0.000189	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP46A1—Alzheimer's disease	1.95e-05	0.000186	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—HTR2A—Alzheimer's disease	1.94e-05	0.000185	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—NOS3—Alzheimer's disease	1.92e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DHCR24—Alzheimer's disease	1.92e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—S100B—Alzheimer's disease	1.92e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—PPARG—Alzheimer's disease	1.9e-05	0.000182	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ND1—Alzheimer's disease	1.88e-05	0.00018	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PPARG—Alzheimer's disease	1.87e-05	0.000179	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	1.84e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—INS—Alzheimer's disease	1.84e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—Alzheimer's disease	1.84e-05	0.000176	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—A2M—Alzheimer's disease	1.83e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF2—Alzheimer's disease	1.83e-05	0.000175	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CALM1—Alzheimer's disease	1.81e-05	0.000173	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—LEP—Alzheimer's disease	1.8e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—APOE—Alzheimer's disease	1.8e-05	0.000172	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CAV1—Alzheimer's disease	1.78e-05	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.78e-05	0.00017	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PSEN2—Alzheimer's disease	1.77e-05	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1R—Alzheimer's disease	1.77e-05	0.000169	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—Alzheimer's disease	1.76e-05	0.000168	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ESR1—Alzheimer's disease	1.72e-05	0.000164	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—F2—Alzheimer's disease	1.7e-05	0.000162	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LPL—Alzheimer's disease	1.69e-05	0.000162	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—Alzheimer's disease	1.68e-05	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MEF2C—Alzheimer's disease	1.68e-05	0.000161	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOTCH1—Alzheimer's disease	1.66e-05	0.000159	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—PRKCG—Alzheimer's disease	1.65e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CA4—Alzheimer's disease	1.64e-05	0.000157	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NPY—Alzheimer's disease	1.63e-05	0.000156	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.62e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IAPP—Alzheimer's disease	1.62e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NOS3—Alzheimer's disease	1.61e-05	0.000154	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NGF—Alzheimer's disease	1.6e-05	0.000153	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ESR1—Alzheimer's disease	1.59e-05	0.000152	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CRH—Alzheimer's disease	1.57e-05	0.00015	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCR5—Alzheimer's disease	1.56e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GSK3B—Alzheimer's disease	1.56e-05	0.000149	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CREB1—Alzheimer's disease	1.55e-05	0.000148	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GAPDHS—Alzheimer's disease	1.54e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—INS—Alzheimer's disease	1.54e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NOTCH1—Alzheimer's disease	1.53e-05	0.000147	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—HTR2A—Alzheimer's disease	1.53e-05	0.000146	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CCL2—Alzheimer's disease	1.51e-05	0.000145	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—AKT1—Alzheimer's disease	1.5e-05	0.000144	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NPS—Alzheimer's disease	1.49e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CHAT—Alzheimer's disease	1.49e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—TPI1—Alzheimer's disease	1.49e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1—Alzheimer's disease	1.49e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PPP3CA—Alzheimer's disease	1.48e-05	0.000142	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—Alzheimer's disease	1.47e-05	0.000141	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PTK2B—Alzheimer's disease	1.46e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ATP5A1—Alzheimer's disease	1.46e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARGC1A—Alzheimer's disease	1.45e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—PPARG—Alzheimer's disease	1.45e-05	0.000139	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MAOB—Alzheimer's disease	1.43e-05	0.000137	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CALM1—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NTRK2—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GAB2—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SST—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—APOE—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—LEP—Alzheimer's disease	1.42e-05	0.000136	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GSK3A—Alzheimer's disease	1.41e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CAV1—Alzheimer's disease	1.41e-05	0.000135	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLD3—Alzheimer's disease	1.39e-05	0.000133	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APP—Alzheimer's disease	1.38e-05	0.000132	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GAPDH—Alzheimer's disease	1.37e-05	0.000131	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.36e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ESR1—Alzheimer's disease	1.35e-05	0.00013	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—NOS3—Alzheimer's disease	1.35e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.35e-05	0.000129	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—F2—Alzheimer's disease	1.34e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HSD17B10—Alzheimer's disease	1.33e-05	0.000128	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—A2M—Alzheimer's disease	1.33e-05	0.000127	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—LPL—Alzheimer's disease	1.32e-05	0.000126	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOTCH1—Alzheimer's disease	1.31e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PLCB1—Alzheimer's disease	1.31e-05	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP46A1—Alzheimer's disease	1.28e-05	0.000123	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFB1—Alzheimer's disease	1.27e-05	0.000122	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ND1—Alzheimer's disease	1.24e-05	0.000119	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GSK3B—Alzheimer's disease	1.23e-05	0.000118	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CREB1—Alzheimer's disease	1.22e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGFR—Alzheimer's disease	1.22e-05	0.000117	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—INS—Alzheimer's disease	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CHAT—Alzheimer's disease	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—TPI1—Alzheimer's disease	1.21e-05	0.000116	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ESR1—Alzheimer's disease	1.2e-05	0.000115	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CCL2—Alzheimer's disease	1.19e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ADAM10—Alzheimer's disease	1.19e-05	0.000114	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	1.18e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NOTCH1—Alzheimer's disease	1.18e-05	0.000113	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1—Alzheimer's disease	1.17e-05	0.000112	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NOTCH1—Alzheimer's disease	1.16e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MAOB—Alzheimer's disease	1.16e-05	0.000111	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ACHE—Alzheimer's disease	1.15e-05	0.00011	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—CASP3—Alzheimer's disease	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—INPP5D—Alzheimer's disease	1.14e-05	0.000109	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—S100B—Alzheimer's disease	1.13e-05	0.000108	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GAPDH—Alzheimer's disease	1.12e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—PPARG—Alzheimer's disease	1.12e-05	0.000107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Alzheimer's disease	1.11e-05	0.000106	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—PPARG—Alzheimer's disease	1.1e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—Alzheimer's disease	1.1e-05	0.000105	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS1—Alzheimer's disease	1.08e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ENO1—Alzheimer's disease	1.08e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—A2M—Alzheimer's disease	1.08e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF2—Alzheimer's disease	1.07e-05	0.000103	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—NOS3—Alzheimer's disease	1.06e-05	0.000102	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP2D6—Alzheimer's disease	1.06e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MAPK8—Alzheimer's disease	1.05e-05	0.000101	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1R—Alzheimer's disease	1.04e-05	9.91e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—BCHE—Alzheimer's disease	1.01e-05	9.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LPL—Alzheimer's disease	9.94e-06	9.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MEF2C—Alzheimer's disease	9.85e-06	9.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—VEGFA—Alzheimer's disease	9.71e-06	9.29e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—PRKCG—Alzheimer's disease	9.66e-06	9.24e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Alzheimer's disease	9.63e-06	9.21e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—IL6—Alzheimer's disease	9.59e-06	9.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PLCB1—Alzheimer's disease	9.49e-06	9.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NGF—Alzheimer's disease	9.41e-06	9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ACHE—Alzheimer's disease	9.39e-06	8.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	9.31e-06	8.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—INPP5D—Alzheimer's disease	9.29e-06	8.88e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ABCA1—Alzheimer's disease	9.2e-06	8.8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCR5—Alzheimer's disease	9.16e-06	8.76e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—CASP3—Alzheimer's disease	9.03e-06	8.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—HTR2A—Alzheimer's disease	8.96e-06	8.57e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFB1—Alzheimer's disease	8.91e-06	8.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—AKT1—Alzheimer's disease	8.85e-06	8.46e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ENO1—Alzheimer's disease	8.8e-06	8.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS1—Alzheimer's disease	8.8e-06	8.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP2D6—Alzheimer's disease	8.63e-06	8.26e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CALM1—Alzheimer's disease	8.36e-06	8e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—APOE—Alzheimer's disease	8.33e-06	7.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—LEP—Alzheimer's disease	8.33e-06	7.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MAPK8—Alzheimer's disease	8.3e-06	7.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CAV1—Alzheimer's disease	8.25e-06	7.89e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—BCHE—Alzheimer's disease	8.18e-06	7.83e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—TPI1—Alzheimer's disease	7.99e-06	7.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CHAT—Alzheimer's disease	7.99e-06	7.64e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARGC1A—Alzheimer's disease	7.93e-06	7.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—HMOX1—Alzheimer's disease	7.89e-06	7.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—F2—Alzheimer's disease	7.85e-06	7.51e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PLCB1—Alzheimer's disease	7.72e-06	7.39e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOTCH1—Alzheimer's disease	7.69e-06	7.35e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MAOB—Alzheimer's disease	7.66e-06	7.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—VEGFA—Alzheimer's disease	7.66e-06	7.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	7.58e-06	7.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—AKT1—Alzheimer's disease	7.52e-06	7.19e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ABCA1—Alzheimer's disease	7.49e-06	7.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—AKT1—Alzheimer's disease	7.41e-06	7.09e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GAPDH—Alzheimer's disease	7.37e-06	7.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—Alzheimer's disease	7.34e-06	7.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—LPL—Alzheimer's disease	7.22e-06	6.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GSK3B—Alzheimer's disease	7.21e-06	6.9e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CREB1—Alzheimer's disease	7.16e-06	6.84e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—A2M—Alzheimer's disease	7.12e-06	6.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—INS—Alzheimer's disease	7.12e-06	6.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFB1—Alzheimer's disease	7.03e-06	6.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CCL2—Alzheimer's disease	7e-06	6.7e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1—Alzheimer's disease	6.88e-06	6.58e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL6—Alzheimer's disease	6.72e-06	6.42e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—MTHFR—Alzheimer's disease	6.5e-06	6.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARGC1A—Alzheimer's disease	6.45e-06	6.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—HMOX1—Alzheimer's disease	6.42e-06	6.14e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—NOS3—Alzheimer's disease	6.24e-06	5.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ACHE—Alzheimer's disease	6.2e-06	5.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—AKT1—Alzheimer's disease	6.2e-06	5.93e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—INPP5D—Alzheimer's disease	6.12e-06	5.86e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CALM1—Alzheimer's disease	6.07e-06	5.81e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—APOE—Alzheimer's disease	6.05e-06	5.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CAV1—Alzheimer's disease	5.99e-06	5.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—LPL—Alzheimer's disease	5.87e-06	5.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS1—Alzheimer's disease	5.81e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ENO1—Alzheimer's disease	5.81e-06	5.55e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—Alzheimer's disease	5.79e-06	5.54e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—AKT1—Alzheimer's disease	5.73e-06	5.48e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CYP2D6—Alzheimer's disease	5.69e-06	5.45e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—BCHE—Alzheimer's disease	5.4e-06	5.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—CASP3—Alzheimer's disease	5.3e-06	5.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL6—Alzheimer's disease	5.3e-06	5.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—MTHFR—Alzheimer's disease	5.29e-06	5.06e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PPARG—Alzheimer's disease	5.27e-06	5.04e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—INS—Alzheimer's disease	5.17e-06	4.94e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PLCB1—Alzheimer's disease	5.09e-06	4.87e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CALM1—Alzheimer's disease	4.94e-06	4.73e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ABCA1—Alzheimer's disease	4.94e-06	4.72e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—APOE—Alzheimer's disease	4.92e-06	4.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—AKT1—Alzheimer's disease	4.89e-06	4.68e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CAV1—Alzheimer's disease	4.88e-06	4.67e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MAPK8—Alzheimer's disease	4.87e-06	4.66e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NOS3—Alzheimer's disease	4.53e-06	4.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—VEGFA—Alzheimer's disease	4.5e-06	4.3e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—AKT1—Alzheimer's disease	4.41e-06	4.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—AKT1—Alzheimer's disease	4.34e-06	4.16e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PPARG—Alzheimer's disease	4.29e-06	4.1e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARGC1A—Alzheimer's disease	4.25e-06	4.07e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—HMOX1—Alzheimer's disease	4.24e-06	4.05e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—INS—Alzheimer's disease	4.21e-06	4.02e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—Alzheimer's disease	4.15e-06	3.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFB1—Alzheimer's disease	4.13e-06	3.95e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—LPL—Alzheimer's disease	3.87e-06	3.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NOS3—Alzheimer's disease	3.69e-06	3.53e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—MTHFR—Alzheimer's disease	3.49e-06	3.34e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—Alzheimer's disease	3.4e-06	3.25e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—Alzheimer's disease	3.37e-06	3.23e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CALM1—Alzheimer's disease	3.26e-06	3.12e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—APOE—Alzheimer's disease	3.25e-06	3.11e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—CAV1—Alzheimer's disease	3.22e-06	3.08e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL6—Alzheimer's disease	3.11e-06	2.97e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—AKT1—Alzheimer's disease	2.87e-06	2.74e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PPARG—Alzheimer's disease	2.83e-06	2.71e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—INS—Alzheimer's disease	2.77e-06	2.65e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NOS3—Alzheimer's disease	2.43e-06	2.33e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—Alzheimer's disease	2.22e-06	2.13e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—AKT1—Alzheimer's disease	2.08e-06	1.99e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—AKT1—Alzheimer's disease	1.7e-06	1.62e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—AKT1—Alzheimer's disease	1.12e-06	1.07e-05	CbGpPWpGaD
